MDLZ vs SPRB · P/E 30, rev $38.54B vs $3.0M cap
Mondelez International Inc (MDLZ) versus Spruce Biosciences Inc (SPRB) — a side-by-side from cached financials, not a winner call.
Mondelez International Inc (MDLZ) is a confectioners company listed on NASDAQ.
Spruce Biosciences Inc (SPRB) is a biotechnology company listed on US.
Latest reported MDLZ revenue for 2025-12-31 was $38.54B. Net income was $2.45B. Revenue was up 5.8% from 2024-12-31 to 2025-12-31. MDLZ currently screens at market cap $78.12B and trailing P/E 30.1.
Latest reported SPRB revenue for 2025-09-30 was $0. Net income was -$24.3M. SPRB currently screens at market cap $3.0M.
MDLZ currently screens at market cap $78.12B and trailing P/E 30.1. SPRB currently screens at market cap $3.0M.
Not investment advice. Open the MDLZ and SPRB stock pages for the full models.
Not investment advice.